- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Natco Pharma Limited — Updates, 10-09-2025: Press Release
10-09-2025 | 11:19 am
10-09-2025 | 11:19 am
NATCO Pharma's subsidiary plans to acquire Adcock Ingram's minority shares for ~ZAR 4 billion (~18,000 Cr), pending shareholder approval. This strategic move aims to delist Adcock Ingram from JSE, significantly expanding NATCO's market footprint in the African continent.
No comments yet. Be the first to comment!